CSL boosts sales, profits
Biotechnology giant, CSL Ltd (ASX: ) boosted sales by 11 per cent and earnings by six per cent in the first half of 2019, according to a statement released to the stock exchange today. The company reported sales revenue of US$4,505 million (Aud$6.300 million) and earnings before interest and tax (EBIT) of $1,553 ($2,160 million)…